Alphabet Inc Class A vs Illumina, Inc. — how do they compare? Alphabet Inc Class A trades at $373.05 (market cap $4.52T), while Illumina, Inc. trades at $189.03 (market cap $28.32B). The key difference: Alphabet Inc Class A is far larger — about 159.6× Illumina, Inc.'s market cap, and Alphabet Inc Class A pays a 0.24% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| GOOGL | ILMN | |
|---|---|---|
Market Cap | $4.52T | $28.32B |
Sector | Media | Health |
52-Week High | $402.62 | $194.33 |
52-Week Low | $182.97 | $91.00 |
Enterprise Value | $4.49T | $29.70B |
Dividend Yield | 0.24% | — |
Signals from Pluang's Aura AI — not financial advice
Alphabet (GOOGL) trades at $359.51, up 1.99% on the day, with a neutral technical signal but bullish moving averages. The company demonstrates strong fundamentals with revenue growing to $402.84B in 2025 and net income surging to $132.17B, yielding a 32.8% profit margin. Recent earnings have consistently beaten expectations, and the company initiated its first dividend. Analyst sentiment remains overwhelmingly positive with an 85% buy rating and a $431.78 consensus price target, suggesting significant upside potential from current levels.
The outlook for GOOGL is positive, driven by robust earnings growth, expanding AI integration across its ecosystem, and strong cash flow generation. Key opportunities include leadership in AI infrastructure, monetization of YouTube and cloud services, and strategic investments like SpaceX. Primary risks involve regulatory scrutiny, intense competition in AI and cloud computing, and potential market volatility. The stock's current valuation, while elevated, is supported by its growth trajectory and dominant market position.
Illumina (ILMN) trades at $191.20, up 0.61% with strong technical momentum near 52-week highs. The company shows robust fundamentals with consistent earnings beats, 19.42% net margin, and improving cash flow. Recent leadership appointments and product launches support growth narrative. Technical indicators show bullish momentum with support at $188 and resistance at $194.
Outlook remains positive with strong sequencing demand and margin expansion driving recovery. Risks include competition from Roche's new sequencer and China market weakness. Analyst consensus is bullish with 51% buy ratings but price target of $174.44 suggests limited upside from current levels.
Trailing returns across standard periods
Latest headlines on both assets
Alphabet, the parent company of Google, earns nearly 90% of its revenue from Google services, mainly through advertising. Other revenue comes from subscriptions (YouTube TV, YouTube Music), platform sales (Play Store purchases), and devices (Pixel, Chromebooks, Chromecast). Google Cloud contributes around 10%, while investments in self-driving cars (Waymo), health (Verily), and internet access (Google Fiber) make up the rest.
Read more on GOOGL →Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →